Literature DB >> 33986149

Early Determination of Prognosis in Neonatal Moderate or Severe Hypoxic-Ischemic Encephalopathy.

Namasivayam Ambalavanan1, Seetha Shankaran2, Abbot R Laptook3, Benjamin A Carper4, Abhik Das5, Waldemar A Carlo6, C Michael Cotten7, Andrea F Duncan8, Rosemary D Higgins.   

Abstract

BACKGROUND AND OBJECTIVES: Early determination of prognosis is important in neonates with hypoxic-ischemic encephalopathy (HIE). Our objective was to test scoring systems developed earlier (original scoring system) and develop new prognostic models.
METHODS: Secondary analysis of data from the multicenter randomized controlled trial of longer, deeper, or usual care cooling in neonatal HIE (NCT01192776) that enrolled 364 neonates diagnosed with moderate or severe HIE. The primary outcome was death or moderate or severe disability at 18 to 22 months, and secondary outcome was death during initial hospitalization. Testing of early neurologic clinical examination (<6 hours of age) and the original scoring system for prognostic ability was done, followed by development of new scoring systems and classification and regression tree (CART) models by using early clinical variables (<6 hours of age).
RESULTS: For death or disability, the original scoring system correctly classified 75% (95% confidence interval: 69%-81%), whereas the new scoring system correctly classified 78% (73%-82%), and the CART model correctly classified 76% (72%-81%). Early neurologic clinical examination also had a correct classification rate of 76% (71%-80%). Depth and duration of cooling did not affect prediction. Only a few components of the early neurologic examination were associated with poor outcome. For death, the original scoring system correctly classified 72% (66%-77%), the new scoring system 68% (63%-72%), the new CART model 87% (83%-90%), and early neurologic evaluation 81% (77%-85%).
CONCLUSIONS: The 3 models (scoring system, CART, and early neurologic evaluation) were comparable in predicting death or disability. For in-hospital death, CART models were superior to scoring systems and early neurologic examination.
Copyright © 2021 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2021        PMID: 33986149      PMCID: PMC8168606          DOI: 10.1542/peds.2020-048678

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   9.703


  29 in total

1.  No cry at birth: global estimates of intrapartum stillbirths and intrapartum-related neonatal deaths.

Authors:  Joy Lawn; Kenji Shibuya; Claudia Stein
Journal:  Bull World Health Organ       Date:  2005-06-17       Impact factor: 9.408

2.  Understanding neurodevelopment in premature infants: applied chaos theory.

Authors:  William MacKendrick
Journal:  J Pediatr       Date:  2006-04       Impact factor: 4.406

3.  Development and reliability of a system to classify gross motor function in children with cerebral palsy.

Authors:  R Palisano; P Rosenbaum; S Walter; D Russell; E Wood; B Galuppi
Journal:  Dev Med Child Neurol       Date:  1997-04       Impact factor: 5.449

4.  Role of EEG background activity, seizure burden and MRI in predicting neurodevelopmental outcome in full-term infants with hypoxic-ischaemic encephalopathy in the era of therapeutic hypothermia.

Authors:  Lauren C Weeke; Geraldine B Boylan; Ronit M Pressler; Boubou Hallberg; Mats Blennow; Mona C Toet; Floris Groenendaal; Linda S de Vries
Journal:  Eur J Paediatr Neurol       Date:  2016-06-20       Impact factor: 3.140

5.  Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: a randomized controlled trial.

Authors:  Susan E Jacobs; Colin J Morley; Terrie E Inder; Michael J Stewart; Katherine R Smith; Patrick J McNamara; Ian M R Wright; Haresh M Kirpalani; Brian A Darlow; Lex W Doyle
Journal:  Arch Pediatr Adolesc Med       Date:  2011-04-04

6.  Amplitude-Integrated Electroencephalography Improves the Identification of Infants with Encephalopathy for Therapeutic Hypothermia and Predicts Neurodevelopmental Outcomes at 2 Years of Age.

Authors:  Janne Helen Skranes; Gro Løhaugen; Eva Margrethe Schumacher; Damjan Osredkar; Andres Server; Frances Mary Cowan; Tom Stiris; Drude Fugelseth; Marianne Thoresen
Journal:  J Pediatr       Date:  2017-05-23       Impact factor: 4.406

7.  Predicting outcomes of neonates diagnosed with hypoxemic-ischemic encephalopathy.

Authors:  Namasivayam Ambalavanan; Waldemar A Carlo; Seetha Shankaran; Carla M Bann; Steven L Emrich; Rosemary D Higgins; Jon E Tyson; T Michael O'Shea; Abbot R Laptook; Richard A Ehrenkranz; Edward F Donovan; Michele C Walsh; Ronald N Goldberg; Abhik Das
Journal:  Pediatrics       Date:  2006-11       Impact factor: 7.124

8.  Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study.

Authors:  H B Sarnat; M S Sarnat
Journal:  Arch Neurol       Date:  1976-10

9.  US birth weight/gestational age-specific neonatal mortality: 1995-1997 rates for whites, hispanics, and blacks.

Authors:  Greg R Alexander; Michael Kogan; Deren Bader; Wally Carlo; Marilee Allen; Joanne Mor
Journal:  Pediatrics       Date:  2003-01       Impact factor: 7.124

10.  Factors associated with follow-up of infants with hypoxic-ischemic encephalopathy in a high-risk infant clinic in California.

Authors:  Vidya V Pai; Peiyi Kan; Tianyao Lu; Erika E Gray; Mihoko Bennett; Maria A L Jocson; Henry C Lee; Suzan L Carmichael; Susan R Hintz
Journal:  J Perinatol       Date:  2020-12-12       Impact factor: 3.225

View more
  2 in total

1.  Dexmedetomidine alleviates olfactory cognitive dysfunction by promoting neurogenesis in the subventricular zone of hypoxic-ischemic neonatal rats.

Authors:  Andi Chen; Xiaohui Chen; Jianhui Deng; Jianjie Wei; Haitao Qian; Yongxin Huang; Shuyan Wu; Fei Gao; Cansheng Gong; Yanling Liao; Xiaochun Zheng
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

2.  Blanket temperature during therapeutic hypothermia and outcomes in hypoxic ischemic encephalopathy.

Authors:  John Flibotte; Abbot R Laptook; Seetha Shankaran; Scott A McDonald; Mariana C Baserga; Edward F Bell; C Michael Cotten; Abhik Das; Sara B DeMauro; Tara L DuPont; Eric C Eichenwald; Roy Heyne; Erik A Jensen; Krisa P Van Meurs; Kevin Dysart
Journal:  J Perinatol       Date:  2022-01-08       Impact factor: 3.225

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.